DANIELA NARDOZI Dottoranda ciclo: XXXIX email: Produzione scientifica 11573/1688031 - 2023 - Curcumin potentiates the ErbB receptors inhibitor Afatinib for enhanced antitumor activity in malignant mesothelioma (01a Articolo in rivista) DANIELA NARDOZI, VALENTINA ANGIOLINI, Valeria LUCARINI, Patrizia MANCINI, Laura MASUELLI11573/1679868 - 2023 - Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo (01a Articolo in rivista) VALENTINA ANGIOLINI, DANIELA NARDOZI, Patrizia MANCINI, Mara CIRONE, ELISABETTA FERRETTI, Laura MASUELLI11573/1671980 - 2023 - Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma (01a Articolo in rivista) DANIELA NARDOZI, VALENTINA ANGIOLINI, Laura MASUELLI11573/1685989 - 2023 - Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion (01g Articolo di rassegna (Review)) Valeria LUCARINI, DANIELA NARDOZI, VALENTINA ANGIOLINI, Monica BENVENUTO, CHIARA FOCACCETTI, ZEIN MERSINI BESHARAT, Laura MASUELLI11573/1678520 - 2023 - Hyaluronan-estradiol nanogels as potential drug carriers to target ER+ breast cancer cell line (01a Articolo in rivista) LUCA PAOLETTI, NICOLE ZORATTO, DANIELA NARDOZI, VALENTINA ANGIOLINI, Patrizia MANCINI, Laura MASUELLI, PIETRO MATRICARDI, Marianna NALLI, Chiara DI MEO11573/1649451 - 2022 - Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo (01a Articolo in rivista) SARA FAZI, MARTA MORETTI, DANIELA NARDOZI, VALENTINA ANGIOLINI, Enrico DE SMAELE, Laura MASUELLI